| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |